Mitsui Chemicals Inc
TSE:4183
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (2.4), the stock would be worth ¥1 776.6 (6% downside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2.6 | ¥1 895 |
0%
|
| 3-Year Average | 2.4 | ¥1 776.6 |
-6%
|
| 5-Year Average | 2.3 | ¥1 677.69 |
-11%
|
| Industry Average | 3.3 | ¥2 425.46 |
+28%
|
| Country Average | 3.7 | ¥2 720.34 |
+44%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Mitsui Chemicals Inc
TSE:4183
|
721.8B JPY | 2.6 | 41.7 | |
| SA |
|
Saudi Basic Industries Corporation SJSC
SAU:2010
|
228.3B SAR | 9.8 | -8.8 | |
| ID |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
45.6B USD | -1 116.8 | 41.8 | |
| ID |
|
Chandra Asri Petrochemical Tbk PT
IDX:TPIA
|
458.5T IDR | -681.8 | 24.8 | |
| US |
|
Dow Inc
NYSE:DOW
|
28.4B USD | 16.3 | -10.8 | |
| UK |
|
LyondellBasell Industries NV
NYSE:LYB
|
23.6B USD | 12.6 | -31.4 | |
| TW |
|
Nan Ya Plastics Corp
TWSE:1303
|
726.5B TWD | 36.8 | 160.8 | |
| CN |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
156.4B CNY | 14.2 | 17.5 | |
| KR |
|
LG Chem Ltd
KRX:051910
|
31.9T KRW | 5.9 | -17.5 | |
| CN |
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
136.3B CNY | 21 | 185.1 | |
| CN |
G
|
Guangzhou Tinci Materials Technology Co Ltd
SZSE:002709
|
120.7B CNY | 21.8 | 42.1 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 2.6 |
| Median | 3.7 |
| 70th Percentile | 5.9 |
| Max | 45 735 393.8 |
Other Multiples
Mitsui Chemicals Inc
Glance View
Mitsui Chemicals Inc. stands as a testament to the transformative power of chemistry, deeply rooted in ingenuity and strategic ventures. Emerging from its storied legacy as part of the Mitsui Group—one of the largest keiretsu in Japan—this corporation has dynamically evolved, becoming a powerhouse in the global chemical industry. Its business model hinges on a diversified portfolio, with an intricate balance of three main segments: Basic Materials, Performance Materials, and Healthcare. Through the Basic Materials sector, Mitsui Chemicals channels its established supply chain and technological prowess to produce fundamental chemicals that serve as building blocks for myriad industries, including automotive, construction, and electronics. By leveraging economies of scale and cutting-edge technology, the company ensures cost-effective production, fostering steady revenue streams. Simultaneously, Mitsui Chemicals capitalizes on burgeoning markets by advancing its more specialized Performance Materials and Healthcare segments. Here, innovation is the linchpin, with the company developing high-performance products such as specialty resins, films, and elastomers—which find applications in everyday consumer goods, medical devices, and renewable energy solutions. The Healthcare division, in particular, demonstrates the firm’s commitment to advancing human wellness and addressing pressing health issues, offering everything from dental materials to diagnostic and therapeutic products. By adeptly combining its innovative capabilities with strong market insights, Mitsui Chemicals not only fuels growth but also secures a resilient foothold in the competitive landscape, translating complex chemical processes into tangible, everyday benefits that drive its financial success.